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INTRODUCTION 
 
The first description of chronic osteomyelitis date back to early 
Sumerian carvings, the fossil was 250 million years old.  At that time the 
mode of treatment was irrigation, immobilisation and bandaging. [1] 
Traditional treatment included the use of honey, donkey faeces and even 
wine. In the past three centuries, the treatment involved the use of local 
ointments.  
 In 1834, Nelaton coined the term osteomyelitis. [2] 
 In Greek, Osteon means bone, myelo means marrow, itis means 
infection.  
 Osteomyelitis is primarily caused by  bacteria . It can also be caused 
by  fungal and even viral infections. Usually occurs in paediatric age group 
and in immunodeficient individuals. 
  Haematogenous osteomyelitis is most common in children. 
Osteomyelitis from adjacent source of infection (diabetic ulcer), post 
trauma, post operative conditions are common in the elderly age group. 
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 Chronic osteomyelitis is identified radiologically by the presence of 
dead necrotic bone and new bone formation and surgically by persisting 
discharging sinus. The fragment of dead bone is called sequestrum.  
In Latin, the words sequester means depositary and sequestrate means 
to give up for safe keeping. 
 In Latin the word involucrum means “enveloping sheath or 
envelope”. 
In osteomyelitis, there is a process of isolation of infective material 
and slow resorption of the infective material by the immune system.  
Mercer Rang in the book “The story of orthopaedics” appreciated the 
development of anaesthesia, antisepsis and radiography for the successful 
development of  orthopaedic surgery. [2] 
 The advent of anaesthetic agent like morphine, heroin increase the 
number of surgical procedures without antisepsis leading to surgical 
infections. 
In 1848, it was Semmelweiss who demonstrated the use of hand wash 
in obstetric delivery reducing maternal mortality from 18% to 1%.  
It was after the discovery of use of disinfectant for surgical hand wash 
by Joseph lister, the father of antiseptic surgery post operative infection 
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decreased dramatically. Use of carbolic acid has reduced mortality from 
43% to 15% in amputation patients.  
  Only in the 19th century, Osteomyelitis was understood as bone 
marrow infection. With the use of antibiotics the incidence of Osteomyelitis 
has decreased significantly.  
The commonest causative organism of Chronic Osteomyelitis is  
 Staphylococcus aureus [32] 
 Coagulase negative staphylococci  
 Pseudomonas 
 Proteus 
 Escherichia coli and  
 Enterococci 
Staphylococcus aureus constitutes 50% – 75% cases of Chronic 
Osteomyelitis [10] 
There is emergence of Gram negative organisms as predominant 
pathogens in Chronic Osteomyelitis following  
 Injury 
 Adjacent septic focus and  
 Prolonged hospital stay of the patient 
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The incidence of anaerobic Osteomyelitis is on the rise because of 
low oxygen tension at the infection site due to the presence of devitalized 
tissue. 
In diabetic patient, Osteomyelitis secondary to foot ulcer is a common 
occurrence. 
 Diabetic patients have 15% lifetime risk to develop pedal ulcer. [46-48] 
In diabetic foot ulcer, the underlying bone gets infected in 66% of the 
patients. [49]  
Apart from having severe infections, prevalence of osteomyelitis in 
diabetic foot ulcers is about 10% to 20%. [50, 51] 
 The mortality, morbidity as a result of Osteomyelitis in diabetic 
patient is very high. Chronic Osteomyelitis is difficult to treat and the 
occurrence of relapse is very high even after successful treatment. 
Removal of dead bone is the gold standard of treatment. [25] 
 The relapse of Osteomyelitis even after 80 years has been 
documented.  
Most common causes of treatment failure is due to  
 Inadequate bone debridement 
 Presence of prosthetic materials  
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 Bacteria hiding in the host endothelial cells and  
 Existing as dormant form in the biofilm  
Due to this Orthopaedic surgeon treat the patient with high dose 
parenteral antibiotic therapy it takes 3 to 4 weeks for the infected bone to 
revascularise.  
The antimicrobial agent of choice depends on 
 the type of organism isolated,  
 their anti microbial susceptibility, 
  pharmaco kinetic factors like bone penetration 
  vascularity of the affected area , 
 presence of any prosthetic material and 
  the patient tolerance to the first line antibiotic. 
The age of the patient and the presence of any vascular insufficiency 
affect the management and prognosis of the patient.  
The use of oral antibiotics in paediatric Osteomyelitis is successful. 
 In adults, the duration of treatment is greater than six weeks 
parenteral for the drug to attain adequate concentration in the bone due to 
vascular insufficiency.  
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The literatures at present are inadequate to guide us about the oral or 
parenteral antibiotic therapy and duration of treatment.  
 
Epidemiology of Osteomyelitis  
In UK incidence of acute haematogenous Osteomyelitis is about 10-
100 / 100,000 of population per year.  
In United States Osteomyelitis incidence is below 2% per annum 
(Paluska).  
It is observed that under the age of 1, the Incidence is more. 
 In children the existence is 1 out 5,000 (King). 
 In subjects treated for acute osteomyelitis, the occurrence of chronic 
osteomyelitis is in the range 5% to 25% in US (Khan).  
Occurrence can go as high as 30% to 40% in people with diabetes and 
16% after foot puncture (King).  
According to Gustilo [11], the occurrence of infection in open 
fractures is 2% to 50%.  
Gustilo and Anderson [12] have classified open fractures depending on 
the extent of soft tissue injury as type 1, 2, 3, 4. 
 The infection rate in type 1 and 2 open fracture is 2%.  
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Type 3 and 4, the infection  rate is 10 to 50%. [11, 12]  
increased incidence of infection in Type 3 and Type 4 open fracture is 
due to gross contamination of wound, loss of overlying skin coverage and 
bone fracture.  
Tibia is the most common site of open fracture and infection. 
 In a retrospective cohort study, open tibial fracture reported 56% of 
infection rate. [13] 
The incidence of post operative infection in simple spinal surgeries is 
1% to 2%. In spinal fusion surgery the infection rate is high 3 to 6% [32, 33] 
due to blood loss, soft tissue injury, and increased duration of surgery.  
Spinal implants act as source of infection and the infection rate is 6 to 
8%. [34, 35] The overall prevalence of Osteomyelitis is 5 to 6%. 
 In a cohort study involved 8905 patients; the incidence of diabetic 
foot ulcer is 5.8% of which 15% developed Osteomyelitis. 
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AIM OF STUDY 
 
 To determine the bacteriological profile of Chronic Osteomyelitis. 
 
 To determine the antimicrobial susceptibility of the bacterial isolates 
of Chronic Osteomyelitis. 
 
 To find out the prevalence of MRSA in Chronic Osteomyelitis 
patients. 
 
 To provide guidelines for empirical antibiotic treatment. 
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REVIEW OF LITERATURE 
 
In 2008, Alok.C.Agrawal et al, In India found, Staphylococcus 
aureus-21, Streptococcus -7, Klebsiella-9, Proteus-7,  E.coli-38 and 
Pseudomonas-29 out of 111 cases of chronic Osteomyelitis. [29] 
In 2011, Vladimir Cordeiro et al, In chronic Osteomyelitis patients 
observed Enterobacter-24.7%, Acinetobacter baumannii-21.4%, 
Pseudomonas aeruginosa-19.8%, Klebsiella pneumonia-8.2%, Serratia 
marcescens-6.6%, Proteus mirabilis-5.7%, Escherichia coli-4.9%, 
Providencia stuarti -2.4%, Morganella morganii-2.4%, Stenotrophomonas 
maltophilia-1.6%, Lecleria adecarboxylata-0.8%, Pantoea agglomerans-
0.8%. They observed below in their study of 121 cases. [28] 
In 2010, Dr.Mita D. Wadekar et al, observed Staphylococcus aureus - 
43%,  Pseudomonas aeruginosa- 10%,  Proteus species - 6%,  E.coli - 5%,  
Klebsiella species - 5%,  Staphylococcus epidermidis - 4%, Enterobacter 
species - 3%, Streptococcus pyogenes - 2% and Enterococcus species - 2%. 
[56] 
In 2008, Kaur J et. al, observed Staphylococcus aureus - 43%, Proteus 
species - 6%, Escherichia coli - 5%,  Enterobacter species -3%,  Klebsiella 
species - 5%. Beta-lactamase resistance in 81.4% strains, Methicillin 
resistance  27.9% in chronic Osteomyelitis patients. [27] 
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In 2001, Haider abdul lateef mousa et. al, observed Staphylococcus - 
45.2% in haematogenous osteomyelitis , Pseudomonas aeruginosa-25% in 
postoperativeosteomyelitis, Anaerobes-26%, Proteus-12.9%. [53] 
In 2008, Ethan Rubinstein et. al, found that hospital-acquired 
pneumonia (HAP) and ventilator-associated pneumonia (VAP) accounts for 
20%–40% of MRSA patients.  All isolates are resistant to erythromycin and 
β-lactams. They also found, Out of 396 patients, 203 received aztreonam 
and linezolid, and 193 received vancomycin and aztreonam. MRSA 
pneumonia was diagnosed in 32 patients. Success rate was 66% for patients 
on linezolid treatment and 68% for patients on vancomycin. [26] 
 Iran, during a 15-month period (January 2004-March 2005), 
Oxacillin resistance was present in 99 of 277 cases (36%) of Staphylococcus 
aureus isolates from blood and wounds. All MRSA isolates were susceptible 
to teicoplanin,vancomycin, , tigecycline and linezolid. Marked resistance of  
MRSA to beta-lactam drugs and high resistance ( > 95% ) to tetracycline, 
azithromycin, kanamycin, erythromycin, gentamicin, and ciprofloxacin is 
observed. [14] 
335 cases out of 358 (93.57%) is Vancomycin sensitive. Sixteen cases 
showed vancomycin intermediate resistance. Vancomycin resistance was 
found in remaining seven isolates. All isolated VRSA were resistant to 
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rifampicin, ceftazidime. 86% were tetracycline susceptible and 71.4% were 
susceptible to chloramphenicol and clarithromycin. [15] 
In eastern Uttar Pradesh India, the prevalence of methicillin resistant 
Staphylococcus aureus (MRSA) is studied, 301 out of 549 specimens of 
Staphylococcus aureus (54.85%) were found to be methicillin resistant. 
MRSA resistance to penicillin, cotrimoxazole, ciprofloxacin, gentamicin, 
erythromycin, tetracycline is >80% ,  60.5% to amikacin and 47.5% to 
netilmicin. No vancomycin resistance was appreciated. 32.0% of MRSA 
strains were multi-drug resistant. [17] 
 In a study conducted South Africa in 2006 for the prevalence of 
MRSA in the KwaZulu-Natal (KZN) province, 26.9% were MRSA and all 
strains were susceptible to teicoplanin, vancomycin. [18] 
In the study conducted during Nov-1998 to Feb-2000, out of  91 
strains of Staphylococcus aureus, 52 isolates MSSA and 39 MRSA.  All 
MSSA were susceptible to vancomycin, gentamicin, teicoplanin, 
ciprofloxacin, rifampicin,  linezolid and quinupristin-dalfopristin. 90% were 
erythromycin susceptible. All the MRSA were susceptible to vancomycin, 
teicoplanin, rifampicin and linezolid, 92% to gentamicin. None of MRSA 
was erythromycin susceptible or ciprofloxacin susceptible. [19] 
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  In the study of anti-biotic sensitivity of Staphylococcus aureus 
Malaysian hospitals, Resistance to penicillin was 94.1%, methicillin 
39.7%, ciprofloxacin 29.2%, clindamycin 2.1%, erythromycin 45.9%, 
gentamicin 40.5%, tetracycline 47.2%, co-trimoxazole 38.5%. All isolates 
are vancomycin sensitive. Erythromycin, gentamicin, tetracycline and 
ciprofloxacin are least susceptible to MRSA. [20] 
Pathogenesis of chronic Osteomyelitis 
Normally adults are resistant to bone infection. Yet there are chances 
for infections that occurs as follows  
 Size of inoculum large, greater than 105 organisms per 
gram of tissue. [7] 
 Presence of devitalised bone and soft tissue. [8,9]  
 Presence of foreign body.  
 The microorganisms which reach the bone or the 
adjacent muscle via blood are from adjacent source of 
infection or open wound contamination. 
Foreign elements like metal ware and bone cement provides surface for 
bacterial colonisation. According to Elek and Conan [23], the presence 
of foreign elements greatly reduces the amount of innoculum required 
to initiate an infection. 
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 Haematogenous spread is an important mode of spread of 
staphylococcus aureus infection. With the help of receptors bacteria 
attaches host proteins. 
A biofilm is an collection of microorganisms embedded in 
glycocalyx. [23] Planktonic Bacterias colonising the biofilm is responsible 
for more than 65%of bacterial infections .The slime layer containing 
glycocalyx help the bacteria to evade the host immune system like 
complement and phagocytosis and impart resistance  to conventional anti 
bacterial therapy. The organisms attached to the dead bone forms bio films. 
[24]  
Pathogenesis of Diabetic Osteomyelitis 
  Peripheral neuropathy is the predominant factor for development of 
diabetic osteomyelitis. [22] 
Bacteriology of Chronic Osteomyelitis  
According to Gustilo and Anderson cultures from open fractures give 
positive results in 70% of cases [36, 37].  
Staphylococcus aureus is the predominant organism in children 
contributing more than 90%.  
In adults, staphylococcus aureus contribute 50% to 75% cases of 
Chronic osteomyelitis. [21]  
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Coagulase negative staphylococcus (staphylococcus epidermidis) and 
gram negative bacilli contribute to 1/3 of infection. [43] 
 
Commonest organisms:  
Gram positive: 
1. Staphylococcus aureus  
2. Staphylococcus epidermidis  
Gram negative: 
1. Escherichia coli  
2. Pseudomonas aeruginosa  
Occasionally encountered organisms: 
Gram positive: 
1. Streptococcus viridans 
2. Enteroccocus faecalis 
3. Diphtheroids 
Gram negative: 
1. Enterobacter cloacae 
2. Klebsiella pneumonia 
25 
 
3. Acinetobacter baumanii 
4. Serratia marcescens 
Anaerobic organisms: 
1. Propionibacterium acnes 
2. Peptococcus species 
3. Peptostreptococcus species 
4. Bacteroides fragilis 
5. Clostridium difficile 
Staphylococcus aeurus: 
Staphylococcus aeurus is a normal commensal organism of anterior 
nares. 
 The staphylococcus are gram positive cocci arranged in clusters and 
they are non sporing, non motile, catalase positive organisms. 
 Staphylococcus contains bound coagulase which binds to fibrinogen 
in the plasma and cause aggregation of staphylococcus. 
 In tube coagulase test, free coagulase causes the plasma to clot. 
Hence staphylococcus is also called coagulase positive staphylococcus. 
Staphylococcus aureus causes pyogenic infections. [6] 
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Morphology and Culture Characteristics: [5] 
 Staphylococcus aureus is 1 micro meter in size.  
 On nutrient agar after 18-24 hrs incubation at 37 deg C forms 
colonies of 1 to 3 mm in diameter, smooth glistening densely 
opaque colonies.  
 In blood agar, the colonies are surrounded by a zone of 
haemolysis.   
 It produces cream to gold colour pigmentation on nutrient agar.  
 In mannitol salt agar it forms yellow colonies 1 mm in diameter 
surrounded by yellow medium due to acid formation. 
Bio Chemical Reactions: 
 Tube Coagulase test positive 
 Bound Coagulase test positive.   
 Voges-Proskauer test positive  
 Lactose fermentation variable 
Staphylococcus epidermidis:  
Staphylococcus epidermidis is the normal commensal of the skin and 
mucous membrane occasionally involved in infective endocardits. 
 Coagulase negative Staphylococcus is the commonest organism 
involved in the prosthetic joint infection followed by Staphylococcus 
27 
 
aureus. Staphylococcus epidermidis together with gram negative baclli 
constitute one-third of cases of chronic osteomyelitis . [43] 
Staphylococcus epidermidis secretes biofilm made of glycocalayx 
which enhances the adherence of bacteria to any necrotic bone or any bone 
implants and bone cement. [41,42,38,39,40] 
Pseudomonas aeruginosa: 
Pseudomonas aeruginosa is widely prevalent in nature. Exotoxin A 
kills host cells by disrupting protein synthesis.  
Osteomyelitis caused by Pseudomonas aeruginosa is more common in 
Intravenous drug addicts. 
 The carrier rate of Pseudomonas aeruginosa in human faeces is less 
than 10%. Prolong hospital stay increases the carrier rate to 30% after 3 
weeks.  
Morphology and Culture Characteristics: [5] 
 Pseudomonas aeruginosa is a gram negative bacilli, catalase 
positive, oxidase positive, motile organism.  
 It produces pigments like pyocyanin, pyorubrin and 
pyomelanin.  
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 On nutrient agar after 24 hrs incubation at 37 deg C produces 
large low convex colonies oval with the long axis in the line of 
innoculum.  
 In MacConKey agar, it produces colourless colonies. 
 It gives characteristic grape like smell due to amino aceto 
phenone.  
 Presence of blue, green pigmented colonies confirms the 
presence of Pseudomonas aeruginosa.  
 Bio Chemical Reactions: 
 Indole Test negative 
 Methyl Red Test negative 
 Voges-Proskauer Test negative  
 In triple sugar iron agar test, sugars are not fermented and H2S 
not produced. 
Escherichia coli: 
Escherichia coli is a member of entero bacteriaceae.  
Morphology and Culture Characteristics: 
 2-4 micrometer x 0.6 micro meter in size, gram negative 
bacilli.  
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 On nutrient agar ,after 18-24 hrs incubation at 37 deg C forms 
colonies of 2 to 3 mm in diameter, smooth low convex 
colonies.  
 In MacConKey agar, it produces lactose fermenting pink 
colour colonies. 
 In blood agar ,the colonies are surrounded by a zone of 
haemolysis. 
Bio Chemical Reactions: 
 Indole positive 
 MR positive 
 Voges-Proskauer test negative 
 Citrate test negative, 
  Urease test negative 
 In triple sugar iron agar test, acid slant by acid butt no H2S 
production 
Klebsiella pneumoniae: 
Klebsiella pneumoniae is a member of enterobacteriaceae family. 
 It is a gram negative bacilli, capsulated organism, non motile, 
oxidase negative, catalase positive organism. 
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Morphology and Culture Characteristics: 
 On MacConKey agar, after 18-24 hrs incubation at 37 deg C, it 
forms lactose fermenting colonies of 2 to 3 mm in diameter, 
smooth convex colonies. 
 In blood agar, large greyish white mucoid colonies are 
produced. 
Bio Chemical Reactions: 
 Indole  negative 
 MR negative 
 Voges-Proskauer test positive 
 Citrate test positive 
 Urease test positive 
 In triple sugar iron agar test, acid slant by acid butt and 
abundant gas production. 
Proteus: 
Proteus is gram negative bacilli, motile, non lactose fermenting, 
catalase  positive organism. 
 Proteus mirabilis is the most common species of Proteus.  
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Morphology and Culture Characteristics: 
On MacConKey agar after 18-24 hrs incubation at 37 deg C, it forms 
non lactose fermenting colonies.  
In young cultures, the bacteria are filamentous reaching upto 80 
micro meter in length. 
 In blood agar plate, swarming of proteus is seen. 
Bio Chemical Reactions: 
 Indole variable 
 MR positive 
 Voges-Proskauer test negative  
 Citrate test variable 
 Urease test positive 
In triple sugar iron agar test, alkaline slant by acid butt with abundant 
H2S production. 
 
  
32 
 
 
MATERIALS AND METHODS 
 
APPROVAL FROM THE ETHICAL COMMITTEE 
The study was approved by the ethical committee of Thanjavur 
Medical College. The informed consent was obtained from all patient who 
are participating in this study.  
 
STUDY PERIOD 
April 2011 to April 2012  
PLACE OF STUDY   
The study was carried out in the department of microbiology, central 
laboratory TMCH . 
COLLABORATING DEPARTMENT  
Collaborating department for the study was department of 
Orthopaedics Surgery, Thanjavur Medical College.  
 
DESIGN OF STUDY 
Observational Study covering bacteriological profile of chronic 
osteomyelitis and their antibiogram.  
33 
 
 
MATERIALS 
 
During the April 2011 to April 2012 study period for this study 50 
patients who were diagnosed clinically and radiologically as a case of 
Chronic Osteomyelitis are participating in this study. The risk factors for 
Chronic Osteomyelitis were obtained from patient case sheets with the help 
of orthopaedic surgeons in the department of orthopaedic TMCH. 
 
INCLUSION CRITERIA      
All cases of chronic osteomyelitis with the following clinical features 
are included in this study 
1. Prolonged history of disease present  
2. Constitutional symptoms are absent  
3. Frequent flare up of infection occurs 
4. Occasionally bony spicules emerges out of the discharging sinus 
5. Restricted neighbouring  joint movement  
6. Deformities like shortening and gross angulations of bone occurs 
due to bone loss     
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EXCLUSION CRITERIA 
The below cases were excluded from this study 
1. Acute osteomyelitis cases  
2. Osteomyelitis due to Anaerobic organisms 
3. Tuberculous osteomyelitis 
EXAMINATION OF CHRONIC OSTEOMYELITIS PATIENTS 
In the orthopaedic TMCH ward general examination of patients was 
done for below details. 
 Age and Sex of the Patient 
 Patients Past history regarding 
  hyper tension, 
  diabetes, 
  smoking , 
 and malignancy. 
 History of present illness 
  duration of illness, 
  type of Osteomyelitis, 
  implantation of any prosthetic implants, 
 To look for any septic focus e.g tonsil, caries tooth, any abscess and 
skin infections 
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 To identify the presence of anaemia 
 To look for diabetic ulcer 
 To rule out mal nutrition 
SAMPLE COLLECTION 
The specimen included bone aspirate and bone curretings are plated 
under aseptic conditions in the ortho ward or in ortho operation theatre. 
Surface swabs are not included in this study.  
PREPRATION OF SMEAR 
Once the bone aspirate is plated, the remaining pus is spread evenly 
on a clean slide and then it is allowed to air dry, and heat fixed by passing 
the slide through the flame intermittently 3-4 times. Then this smear is 
stained by Gram’s staining and viewed under 40x and oil immersion 
microscope to look for the presence of pus cells and micro organisms. 
BACTERIAL CULTURE[52]  
The specimen is plated in Nutrient agar, MacConKey agar and blood 
agar and incubated for 18 hrs at 37 deg C.  
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The organisms isolated were identified by  
 colony morphology,  
 gram staining, 
 Catalase test, 
 Oxidase test,  
 Motility test,  
 Indole test,  
 Methyl Red test, 
  Voges Prausker test, 
  Citrate test, 
 Urease test,  
 Triple sugar Iron Agar test,  
 Coagulase test specific for S.aureus 
The isolates were confirmed and speciated by adapting the standard 
biochemical procedures. 
 Colonies are preserved and maintained in nutrient agar slants.  
ANTI-BACTERIAL  SUSCEPTIBILITY  TEST  PROCEDURE 
In each sterile petri plate, 15-20ml of sterilized MHA medium was 
poured and allowed to become solid. The bacterial test cultures were spread 
evenly on the media by using cotton sterile swab.  
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For Gram positive organisms,   
antimicrobial disc like Amoxycillin, Ampicillin, Erythromycin,   
Gentamicin, Amikacin, Doxycycline, Cotrimoxazole, Ciprofloxacin, 
Cephalexin, Ceftriaxone, Cefotaxime, Cefuroxime s, Oxacillin, Cefoxitin, 
Vancomycin and Linezolid was used. 
For Gram negative organisms,  
 antibiotic disc like Ampicillin,   Gentamicin, Amikacin, 
Doxycycline, Cotrimoxazole, Ciprofloxacin, Cephalexin, Ceftriaxone, 
Cefotaxime, Cefuroxime , Ceftazidime, Ceftazidime +Clavulanic acid and 
Imipenem were tested.  
On agar plates, the discs were kept firm to have complete contact 
with surface of agar. Discs were placed more than 25 mm apart from centre 
and incubated for 16 to 18 hrs at 37 deg C.  Once incubation period is 
complete, the zone of inhibition was measured around each disc and 
interpreting of results is done.  
 
MRSA TEST PROCEDURE 
Cefoxitin Disc Diffusion Test: 
Cefoxitin, an inducer of mecA regulatory system is used as a 
surrogate marker for mecA gene-mediated methicillin resistance detection.  
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MRSA strains with inducible resistance to methicillin grow easily in the 
presence of cefoxitin when compared with oxacillin, due to increased 
induction of PBP 2a by cefoxitin. CLSI recommends cefoxitin disc diffusion 
method for MRSA detection. 
Interpretive Criteria for Cefoxitin Disc Diffusion Test - in mm 
 
Susceptible Resistant 
S. aureus 
≥ 22 mm ≤ 21 mm 
CoNS 
≥ 25 mm ≤ 24 mm 
 
Method: 
A  0.5  Mc Farland standard suspension is prepared and lawn culture 
is made using MHA plate.  A 30 µg cefoxitin disc is placed and incubated at 
37 deg C for 18 hours and zone diameter is measured in the presence of 
reflected light.  If the zone of inhibition diameter >22mm is considered as 
methicillin sensitive and  < 21mm is reported methicillin resistant. Latest 
studies indicate disc diffusion tests using cefoxitin disc superior compared 
to other methods.  According to CLSI guidelines, the cefoxitin disc will 
detect MRSA with mecA gene mediated resistance. 
 
 
39 
 
Oxacillin Disc diffusion test: 
A 0.5 McFarland standard suspension of S. aureus is prepared and 
plated on Mueller-Hinton agar with 2-4% NaCl.  An oxacillin disc(1µg) is 
kept on surface and incubated at 37 deg C for 18 hours. Oxacillin disc is 
resistant to degradation on storage and detects heteroresistant strains. In 
transmitted light, the zone of inhibition is measured.  Zone diameter >13mm 
is sensitive and <10 mm is considered resistant.   
Interpretive Criteria for Oxacillin Disc Diffusion Test - in mm 
 Susceptible Resistant 
S. aureus 
≥ 13 mm ≤  10 mm 
CoNS 
≥ 18 mm ≤  17 mm 
 
READING AND INTERPRETATION OF RESULTS  
After completion of 16 to 18 hrs of incubation period, each plate was 
examined for uniformly semi confluent of growth and circular zones of 
inhibition around the individual disc. Petri plate was examined to measure 
diameter of zones of inhibition using zone scale that was held by inverting 
Petri plate. The Petri plate was held a few inches above a black, non 
reflecting background and illuminated with reflected light. 
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 The disc around which there is no growth of appropriate diameter 
when measured will indicate whether the organism is sensitive or 
intermediately sensitive or resistant to the drug. The sizes of the zones of 
inhibition were interpreted by referring to the CLSI standards and reported 
as susceptible, intermediate or resistant to the drugs that were tested. 
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ZONE SIZE INTERPRETATION CHART AS PER CLSI [4] 
 
S.No 
Antimicrobial 
agent 
Symbol 
Disc. Conc 
(μg) 
Zone size in mm 
    
Resistant Intermediate Sensitive 
1 Amoxycillin AMX 10 - - 28-36 
2 Cotrimoxazole COT 1.25/23.75 10 11-15 16 
3 Doxycycline DO 30 12 13-15 16 
4 Ampicillin  AMP 10 <13 14-16 >17 
5 Oxacillin OX 1 10 11-12 13 
6 Cephalexin  CH 30 <14 15-17 >18 
7 Cefotaxime  CTX 30 <13 14-20 >21 
8 Ceftriaxone  CTR 30 <13 14-20 >21 
9 Cefuroxime CXM 30 14 15-17 18 
10 Ceftazidime  CAZ 30 <14 15-17 >18 
11 
Ceftazidime + 
Clavulanic acid  
CAC 30/10 - - 27-34 
12 Gentamicin  GEN 10 < 12 13-14 > 15 
13 Amikacin  AK 30 <14 15-16 >17 
14 Ciprofloxacin  CF 5 <15 16-20 >21 
15 Imipenem  IMP 10 <13 14-15 >16 
16 Vancomycin VA 30 - - 15 
17 Linezolid LZ 30 - - 25-32 
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ACTERIAL CULTURE PLATES AND ITS ANTI MICROBIAL 
SUSCEPTIBILITY 
 
 
Figure 12 : Colony of Staphylococcus aureus in MacConKey Agar Plate 
 
 
 
Figure 13 : Colony of Staphylococcus aureus in Blood Agar Plate 
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Figure 14 : Colony of Staphylococcus aureus in Mannitol salt Agar Plate 
 
 
 
 
Figure 15 : Coagulase Test Positive - Staphylococcus aureus 
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Figure 16 : Coagulase Test Negative – Staphylococcus epidermidis 
 
 
 
Figure 17 : Antibiogram of S.aureus sensitive to oxacillin & vancomycin 
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Figure 18 : Oxacillin Sensitive Staphylococcus aureus 
 
 
 
Figure 19 : Colony of Klebsiella pneumoniae in MacConKey Agar Plate 
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Figure 20 : Biochemical reactions of Klebsiella pneumoniae 
 
 
 
 
Figure 21 : Colony of Proteus vulgaris in MacConKey Agar Plate 
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Figure 22 : Biochemical reactions of Proteus vulgaris 
 
 
 
 
 
 
 
 
 
 
Figure 12 : Colony of Escherichia coli in MacConKey Agar Plate 
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Figure 233 : Biochemical reactions of Escherichia coli 
 
 
 
Figure 14 : Polymicrobial Growth  
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Figure 245 : Antimicrobial Susceptibility Plate - Pseudomonas colony 
sensitive to Imipenem 
 
 
Figure 16 :  McFarland’s turbidity standard 
 
50 
 
 
RESULTS 
 
In this study, the total number of cases Chronic Osteomyelitis 
considered was 50. 
1. Following Haematogenous Osteomyelitis – 3 cases 
2. Trauma – 30 cases 
a. Trauma patients without diabetes – 24 
b. Trauma patients with diabetes as risk factor– 6 
3. Postoperative  Osteomyelitis – 17 cases 
a. Postoperative patients without implants – 10 
b. Postoperative patients with prosthetic implants – 7 
Table 1: Percentage of Bones Involved in Chronic Osteomyelitis 
 
 
 
 
 
 
 
 
 
S.No Bones Involved Number of cases 
1 Femur 23 
2 Tibia 15 
3 Femur + Tibia 2 
4 Tibia + Fibula 3 
5 Radius + Ulna 4 
6 Humerus 2 
7 Acetabulum 1 
 Total  50 
51 
Bones involvement in Chronic Osteomyelitis 
The involvement of long bones in Chronic Osteomyelitis is as follows 
1. Femur – 46% 
2. Tibia – 30% 
3. Femur + Tibia – 4% 
4. Tibia + Fibula – 6% 
5. Radius+ Ulna – 8% 
6. Humerus – 4% 
7. Acetabulum – 2% 
Chart 1 : Percentage of Bones Involved in Chronic Osteomyelitis  
                 (Bar Chart 3D View) 
 
 
 
 
0
5
10
15
20
25 23
15
2 3
4
2 1
52 
 
 
Chart 2 : Percentage of Bones Involved in Chronic Osteomyelitis 
                 (PIE Exploded 3D View) 
 
 
 
The incidence of Osteomyelitis in males is 84% and female is16%. 
And the male to female ratio is 5.25:1 
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Age & Sex distribution of Chronic Osteomyelitis 
The incidence of Osteomyelitis in different age group is as follows 
1. 1-20 years– 20% 
2. 21-40 years – 40% 
3. 40-65 years – 40% 
Table 2: Age & Sex Distribution of Chronic Osteomyelitis 
   
S.No Age Group Male Female  
1 1-20 Years 7 3  
2 21-40 Years 19 1  
3 41-65 Years 16 4  
 Total No of Cases 42 
 
8 
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Chart 3 : Age & Sex Distribution of Chronic Osteomyelitis  
                (Bar Chart 3D View) 
 
 
 
Chart 4 : Age & Sex Distribution of Chronic Osteomyelitis (PIE EXPLODED - 
3D View) 
Inner Ring – Females  
Outer Ring - Males 
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Bacterial culture results 
The Bacterial culture results is given below 
1. No of samples with positive cultures – 45 cases 
a. Monomicrobial growth – 40 cases 
b. Polymicrobial growth – 5 cases 
2. No growth was obtained – 5 cases 
 
Table 3: Culture Results 
 
S.No Type of Growth Number 
1 Monomicrobial growth  40 
2 Polymicrobial growth 5 
3 Negative growth 5 
Total 50 
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Chart 5 : Culture Results (Bar Chart 3D View) 
 
 
 
 
Chart 6 : Culture Results (PIE 3D View) 
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Monomicrobial growth 
For Monomicrobial growth (40 isolates), 
 organisms isolated is as follows 
1. Staphylococcus aureus – 25 isolates  
2. Coagulase negative staphylococci – 7 isolates 
3. Escherichia coli – 2 isolates 
4. Klebsiella – 2 isolates 
5. Pseudomonas – 2 isolates  
6. Proteus – 1 isolate 
7. Enterococci – 1 isolate 
 
Table 4: Monomicrobial Growth 
 
  
S.No Pathogen Number 
1 Staphylococcus aureus   25 
2 Coagulase Negative Staphylococci 7 
3 Escherichia coli  2 
4 Klebsiella  2 
5 Pseudomonas 2 
6 Proteus 1 
7 Enterococci 1 
Total  40 
58 
Chart 7 : Monomicrobial Growth (Bar Chart 3D View) 
 
 
 
 
Chart 8 : Monomicrobial Growth (PIE DONUT 3D View) 
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Polymicrobial growth 
For Polymicrobial growth (5 isolates), 
 organisms isolated is as follows 
1. Staphylococcus aureus+pseudomonas – 2 isolates 
2. Staphylococcus aureus + E.coli – 1 isolates 
3. Staphylococcus aureus + Proteus – 1 isolate 
4. Klebsiella + Pseudomonas – 1 isolate 
 
Table 5: Polymicrobial Growth 
 
 
  
S.No Pathogen Number 
1 S.aureus + Pseudomonas  2 
2 S.aureus +E.coli 1 
3 S.aureus + Proteus  1 
4 Klebsiella + Pseudomonas 1 
Total  5 
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Chart 9 : Polymicrobial Growth (Bar Chart 3D View) 
 
 
 
 
Chart 10 : Poly microbial Growth (PIE 3D View) 
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Pathogens associated with risk factors 
1. Postoperative cases with Prosthetic Implants – 7 cases. 
 Pathogens isolated is as given below 
a) Staphylococcus aureus – 2 isolates 
b) Coagulase  negative  staphylococci – 3 isolates 
c) Escherichia coli – 1 isolate 
d) Enterococci – 1 isolate 
 
2. In trauma patients with Diabetes – 6 cases. 
 Pathogens isolated is as given below 
a. Staphylococcus aureus – 3 isolates 
b. Staphylococcus aureus + E.coli – 1 isolates 
c. Staphylococcus aureus + Pseudomonas – 1 isolates 
d. Klebsiella – 1 isolate 
Antimicrobial susceptibility of Staphylococcus aureus – 29 cases 
a. MSSA- 17 
b. MRSA-12 
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Antimicrobial susceptibility of MSSA 
MSSA Antibiogram 
 
Drug Cases % Sensitive % Resistance 
amoxycillin 
0 0 100 
ampicillin 
0 0 100 
cotrimoxale 
13 76 24 
doxycycline 
15 88 12 
erythromycin 
13 76 24 
amikacin 
15 88 12 
gentamicin 
13 76 24 
ciprofloxacin 
11 65 35 
cephalexin 
10 59 41 
Oxacillin 
17 100 0 
cefotaxime 
10 59 41 
cefuroxime 
13 76 24 
ceftriaxone 
13 76 24 
vancomycin 
17 100 0 
 
The sensitivity of Methicillin sensitive Staphylococcus aureus for the 
following drugs is as follows 
amoxycillin - 0%, ampicillin - 0%, cotrimoxale - 76%, doxycycline - 88%, 
erythromycin - 76%, amikacin - 88%, gentamicin - 76%, ciprofloxacin  - 
65%, cephalexin - 59%, oxacillin - 100%, cefotaxime - 59%, cefuroxime - 
76%, ceftriaxone - 76%, vancomycin - 100%. 
63 
 
Antimicrobial susceptibility of MRSA 
MRSA Antibiogram 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The sensitivity of Methicillin resistant Staphylococcus aureus for the 
following drugs is as follows 
amoxycillin - 0%, ampicillin - 0%, cotrimoxale - 83%, doxycycline - 50%, 
erythromycin - 58%, amikacin - 25%, gentamicin - 17%, ciprofloxacin  - 
0%, cephalexin - 0%, oxacillin - 0%, cefotaxime - 0%, cefuroxime - 8%, 
ceftriaxone - 17%, vancomycin - 100%, linezolid - 75%.  
Drug  Cases % Sensitive % Resistance 
Amoxicillin 
0 0 100 
Ampicillin 
0 0 100 
Cotrimoxale 
10 83 17 
Doxycycline 
6 50 50 
erythromycin 
7 58 42 
Amikacin 
3 25 75 
Gentamicin 
2 17 83 
ciprofloxacin  
0 0 100 
Cephalexin 
0 0 100 
Oxacillin 
0 0 100 
Cefotaxime 
0 0 100 
Cefuroxime 
1 8 92 
Ceftriaxone 
2 17 83 
Vancomycin 
12 100 0 
Linezolid 
9 75 25 
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Antimicrobial susceptibility of Coagulase negative Staphylococcus  
The sensitivity of Coagulase negative Staphylococcus for the following 
drugs is as follows 
amoxycillin - 29%, ampicillin - 43%, cotrimoxale - 57%, doxycycline - 
71%, erythromycin - 57%, amikacin - 71%, gentamicin - 57%, ciprofloxacin  
- 43%, cephalexin - 57%, oxacillin - 100%, cefotaxime - 86%, cefuroxime - 
71%, ceftriaxone - 86% 
Drug  Cases % Sensitive % Resistance 
amoxycillin 
2 29 71 
Ampicillin 
3 43 57 
cotrimoxale 
4 57 43 
doxycycline 
5 71 29 
erythromycin 
4 57 43 
Amikacin 
5 71 29 
gentamicin 
4 57 43 
ciprofloxacin  
3 43 57 
Cephalexin 
4 57 43 
Oxacillin 
7 100 0 
Cefotaxime 
6 86 14 
Cefuroxime 
5 71 29 
ceftriaxone 
6 86 14 
 
Antimicrobial susceptibility of Enterococci 
The sensitivity of Enterococci is studied with 1 case. 
 And it is found to be resistant to all drugs except vancomycin. 
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Antimicrobial susceptibility of Escherichia coli 
The sensitivity of  Escherichia coli is studied with 3 cases. 
 And its sensitivity pattern for the following drugs is as follows: 
 ampicillin - 0%, cotrimoxale - 33%, doxycycline - 67%, amikacin - 67%, 
gentamicin - 67%, ciprofloxacin  - 67%, cephalexin - 33%, cefotaxime - 
67%, cefuroxime - 33%, ceftriaxone - 167%, ceftazidime - 67%, 
ceftazidime - clavulanic acid - 67%, imipenem - 100% 
 
Antimicrobial susceptibility of Pseudomonas aeruginosa 
The sensitivity of  Pseudomonas aeruginosa is studied with 5 cases. 
 And its sensitivity pattern for the following drugs is as follows:  
ampicillin - 0%, cotrimoxale - 0%, doxycycline - 0%, amikacin - 40%, 
gentamicin - 20%, ciprofloxacin  - 40%, cephalexin - 20%, cefotaxime - 
20%, cefuroxime - 20%, ceftriaxone - 40%, ceftazidime - 60%, ceftazidime 
- clavulanic acid - 80%, imipenem - 100% 
 
Antimicrobial susceptibility of Klebsiella Pneumoniae 
The sensitivity of  Klebsiella Pneumoniae is studied with 3 cases. 
 And its sensitivity pattern for the following drugs is as follows:  
ampicillin - 0%, cotrimoxale - 33%, doxycycline - 33%, amikacin - 67%, 
gentamicin - 33%, ciprofloxacin  - 67%, cephalexin - 33%, cefotaxime - 
67%, cefuroxime - 33%, ceftriaxone - 67%, ceftazidime - 67%, ceftazidime 
- clavulanic acid - 100%, imipenem - 100% 
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Antimicrobial susceptibility of Proteus vulgaris 
The sensitivity of  Proteus vulgaris is studied with 2 cases. 
 And its sensitivity pattern for the following drugs is as follows:   
 ampicillin - 0%, cotrimoxale - 0%, doxycycline - 0%, amikacin - 100%, 
gentamicin - 100%, ciprofloxacin  - 100%,cephalexin - 100%, cefotaxime - 
100%, cefuroxime - 50%, ceftriaxone - 100%, ceftazidime - 100%, 
ceftazidime - clavulanic acid - 100%, imipenem - 100%, 
Antimicrobial susceptibility pattern of Gram negative bacilli 
 
Drug  Pseudomonas n-5 
E.coli 
n-3 
Klebsiella 
n-3 
Proteus 
n-2 
Ampicillin 0%(0) 0%(0) 0%(0) 0%(0) 
Cotrimoxale 0%(0) 33%(1) 33%(1) 0%(0) 
Doxycycline 0%(0) 67%(2) 33%(1) 0%(0) 
Amikacin 40%(2) 67%(2) 67%(2) 100%(2) 
Gentamicin 20%(1) 67%(2) 33%(1) 100%(2) 
ciprofloxacin  40%(2) 67%(2) 67%(2) 100%(2) 
Cephalexin 20%(1) 33%(1) 33%(1) 100%(2) 
Cefotaxime 20%(1) 67%(2) 67%(2) 100%(2) 
Cefuroxime 20%(1) 33%(1) 33%(1) 50%(1) 
Ceftriaxone 40%(2) 167%(5) 67%(2) 100%(2) 
Ceftazidime 60%(3) 67%(2) 67%(2) 100%(2) 
ceftazidime - clavulanic 
acid 80%(4) 67%(2) 100%(3) 100%(2) 
Imipenem 100%(5) 100%(3) 100%(3) 100%(2) 
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DISCUSSION 
 
In this study occurrence of haematogenous osteomyelitis is only 6%.  
The development of Osteomyelitis depends on the host and microbial 
factors. The host factors include destruction of cartilage, resorption of bone. 
Microorganisms play dominant role in the development of Osteomyelitis. 
 
In this study commonest pathogen in haematogeneous osteomyelitis 
is S.aureus 66% (2/3 cases),  
 it coincides with the findings of Lipsky et al. [54]. In developed 
countries, Lipsky says haematogenous osteomyelitis is completely wiped 
out.  
In a study by Haider Abdul-Lateef Mousa et al, in haematogenous 
osteomyelitis the most causative agent was Staphylococcus aureus (45.2%). 
[53] 
In this study, incidence of Osteomyelitis in males is 84% and females 
16% , male female ratio is 5.25:1 , where as it is 1.9:1 according to Haider 
Abdul-Lateef Mousa et al. [53] 
In this study occurrence of Staphylococcus aureus is 58% and 
Coagulase negative Staphylococci is 14%.  
 
68 
 
This study correlates with the study of the following people, 
According to Mader et.al the occurrence of osteomyelitis is due to 
Staphylococcus aureus and Coagulase negative Staphylococci is 75% 
followed, by gram negative organisms and anaerobes. [3] 
In a study by Saurabh Agarwal, Mohd Zahid, Mohd K.A et al. 
Staphylococcus aureus is the most common organism followed by 
Streptococcus, Pseudomonas, Proteus, E.coli and Klebsiella. [55] 
R.D. Char, N.S. Brara, K.D.Khare et al.(1975), in their study 19 out 
of  27 patients  had positive culture of Staphylococcus aureus 70.37%. 
Augsburg  J (1991) found Staphylococcus aureus was the commonest 
organism in a study in the pathogens and their antibiogram conducted with 
79 osteomyelitis patients. 
  According to the study by Kaur J , Gulati VL , Aggarwal A, Gupta v 
(2008) et al. on 100 patients in North India hospitals found Staphylococcus 
aureus in 43%. 
According to Sheehy SH, Atkins BA, Bejon P  (2010) et al. on 166 
patients in Oxford U.K. observed  Staphylococcus aureus in 32%.. 
According to Mita D. Wadekar (2010) et al. [56] observed, 
Staphylococcus aureus in 43% followed by Pseudomonas 10%, Proteus 
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species 6%, Klebsiella 5%, E.coli 5%, Staphylococcus epidermidis 4%, 
Enterobacter 3%  and Enterococci 2% . 
This study doesn’t correlate with the study of the following people, 
In 2008, Alok.C.Agrawal et al, found Staphylococcus aureus in 21 
out of 111 cases in India. [29] 
A.K. Ako-Nai , I.C Ikem ,A.Aziba et al.(2003) conducted a study on 
bacteriological examination of chronic osteomyelitis in southwestern 
Nigeria concluded Staphylococcus aureus 20.5%, Coagulase negative 
Staphylococci is 12.8% 
 
In this study, Coagulase negative Staphylococci is the second 
commonest pathogen with 14% occurrence . 
This study correlates with the study of the following people, 
A.K. Ako-Nai , I.C Ikem ,A.Aziba et al.(2003) found Coagulase 
negative Staphylococci in 12.8% of their cases under study. 
According to Waldvogel  et al. Staphylococcus aureus + Coagulase 
negative Staphylococci in 75%. 
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In this study, the occurrence of Enterococci is 2% . 
This study correlates with the study of the following people, 
According to Kaur J , Gulati VL , Aggarwal A, Gupta v (2008) et al. 
the incidence of  Enterococci is 2% in their study. 
 
In this study, the occurrence of gram negative bacilli is E.coli 6%, 
Klebsiella 6%, Pseudomonas 10%, Proteus 4%. 
This study correlates with the study of the following people, 
Dr Mita D. Wadekar (2010) et al [56], observed the occurrence of 
Pseudomonas 10%, Proteus species 6%, Klebsiella 5%, E.coli 5%, 
Staphylococcus epidermidis 4%, Enterobacter 3%  and Enterococci 2% .  
This study doesn’t correlate with the study of the following people, 
In 2008, Alok.C.Agrawal et al, In India found, Pseudomonas 29%, 
E.coli 38%, Klebsiella 9%, Proteus species 7%. [29] 
In 2010, Haider Abdul-Lateef Mousa et al, in post operative 
osteomyelitis observed Pseudomonas 25%, Proteus species 12.9%  [53] 
In this study, 5 out of 50 cases showed no growth. The absence of 
growth may be due to anaerobic organism. 
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According to Haider Abdul-Lateef Mousa et al, incidence of 
osteomyelitis due to anaerobic bacteria is significant, because anaerobes 
multiply easily in dead tissue due to low oxygen tension.  
Chronic osteomyelitis associated with prosthetic implants as risk factor. 
In this study, no of cases with prosthetic implants is 7. 
 Coagulase-negative staphylococci 43% ( 3 cases) ,  
 Staphylococcus aureus 28% (2) 
 Enterococci 14% (1) 
 E.coli 14% (1) 
Coagulase-negative staphylococci is more prevalent than 
Staphylococcus aureus in prosthetic joint infections. [57] 
Enterococci and Streptococcus viridans also cause prosthetic joint 
infections. [58] 
Enterococci and Gram negative bacilli from the gastrointestinal tract 
casues prosthetic joint infections.[61] 
Staphylococcus aureus and Staphylococcus epidermidis together 
cause about 65% of Prosthetic joint infections. [59, 60] 
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Chronic osteomyelitis associated with diabetes.  
In this study, number  of cases of osteomyelitis patient with diabetes is 6. 
 Monomicrobial growth - 4 
 Staphylococcus aureus - 3 
 Klebsiella - 1 
 Polymicrobial growth - 2 
 Staphylococcus aureus + E.coli - 1 
 Staphylococcus aureus + Pseudomonas - 1 
The percentage of  occurrence of pathogens is listed below 
 Staphylococcus aureus - 63% 
 E.coli - 12% 
 Klebsiella - 12% 
 Pseudomonas - 12% 
 
This study correlates with the study of the following people, 
Diabetic osteomyelitis are caused by single micro-organism. 
Staphylococcus aureus along with coagulase negative staphylococci 
accounts for 70-80% of such cases. [62, 63] 
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This study doesn’t correlate with the study of the following people, 
According' to Eric Senneville et al, Occurrence of micro-organisms in 
bone samples were staphylococci (52%) and gram-negative bacilli (18.4%). 
[31] 
According to the study by Asha Konipparambil Pappu , Aprana 
Sinha, Aravind Johnson et al, Occurrence of Pathogens is Staphylococcus 
aureus 21%, Pseudomonas 23%,  Proteus mirabilis (15%), Klebsiella (17%), 
E. coli (12%). [30] 
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Discussion on Anti Microbial Susceptibility of Staphylococcus aureus 
Of the 29 isolates of Staphylococcus aureus,  MSSA - 58%, MRSA 42%. 
This study correlates with the study of the following people, 
In 2008, Ethan Rubinstein et. al, found  20%–40%  of  MRSA 
patients.  All isolates are resistant to erythromycin and β-lactams, 2.Success 
rate was 66% for patients on linezolid treatment and 68% for patients on 
vancomycin. [29] 
According to Fatholahzadeh et. al,  MRSA  is 36% . All MRSA 
isolates were susceptible to vancomycin, linezolid. Complete  resistance  to 
beta-lactam drugs and high resistance ( > 95% ) to tetracycline, 
erythromycin, gentamicin, and ciprofloxacin is observed. [14] 
According to Marcinak et al, Trimethoprim-sulfamethoxazole is used 
for the treatment of methicillin-resistant Staphylococcus aureus in children, 
and emerging option for treatment is linezolid. [16] 
According to S Anupurba et al,  In eastern Uttar Pradesh., MRSA is 
(54.85%). MRSA resistance to penicillin, cotrimoxazole, ciprofloxacin, 
gentamicin, erythromycin, tetracycline is >80%  and 60.5% to amikacin. No 
vancomycin resistance was appreciated. [17] 
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 In According to Adebayo O Shittu et al, 26.9% were MRSA and all 
strains were susceptible to teicoplanin, vancomycin. [18] 
According to Viudes A et al, MRSA is 42.85%.  All MSSA were 
susceptible to vancomycin, gentamicin, teicoplanin, ciprofloxacin and 
linezolid. 90% were erythromycin susceptible. All the MRSA were 
susceptible to vancomycin and linezolid, 92% to gentamicin. [19] 
According to Rohani MY et al, MRSA 39.7%, Resistance to 
penicillin was 94.1%, ciprofloxacin 29.2%, erythromycin 45.9%, 
gentamicin 40.5%, tetracycline 47.2%, co-trimoxazole 38.5%. All isolates 
are vancomycin sensitive. Erythromycin, gentamicin, tetracycline and 
ciprofloxacin are least susceptible to MRSA. [20] 
In this study in antimicrobial susceptibility test, the sensitivity for 
different drugs are vancomycin (100%), linezolid (75%), cotrimoxale 
(83%), doxycycline (50%) and erythromycin (58%). 
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SUMMARY 
 
This study on Chronic Osteomyelitis was conducted at Central Lab 
TMCH, from April 2011 to April 2012  in  50  patients. 
 Staphylococcus aureus (58%) is the dominant pathogen followed by 
Coagulase negative Staphylococcus (14%) causing Chronic 
Osteomyelitis. 
 Gram negative bacilli E.coli, Klebsiella, Pseudomonas and Proteus 
constitute 26% infections. 
 80% of  Osteomyelitis occurs in 20-65 years age group. 
 In Monomicrobial growth, the commonest organism is 
Staphylococcus aureus, followed by CoNS, E. coli, Klebsiella and 
Pseudomonas 
 In Polymicrobial growth, 
 the commonest organism is Staphylococcus aureus followed by 
Pseudomonas, E. coli and Proteus. 
 In post operative patients with prosthetic implants, 
 commonest organism isolated is Coagulase negative staphylococci 
(42%) followed by Staphylococcus aureus (28%), Enterococci (14%) 
and E.coli (14%). 
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 In trauma patients with diabetes, the commonest organism is S.aureus 
(63%) followed by E.coli (12%), Klebsiella (12%) and Pseudomonas   
(12%). 
 Out of 29 cases Staphylococcus aureus,  17 cases were MSSA (58%) 
and 12 were MRSA (42%). 
 In antimicrobial susceptibility test, the sensitivity for different drugs 
are vancomycin (100%), linezolid (75%), cotrimoxale (83%), 
doxycycline (50%) and erythromycin (58%). 
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CONCLUSION 
 
Chronic Osteomyelitis is a chronic disease most commonly occurring 
in adults with the involvement of long bones especially femur and tibia. 
Due to the advent of antibiotics and high vascular metaphysis of growing 
bones in children, the occurrence of haematogenous Osteomyelitis is 
coming down. In this study staphylococcus aureus is the commonest 
organism causing Chronic Osteomyelitis .The Methicillin Resistant 
Staphylococcus aureus is sensitive vancomycin and 
linezolid.Cotrimoxazole , doxycyline , erythromycin can also be used for 
the treatment of MRSA.The injudicious use of antibiotics has led to 
development of MRSA and resistance to betalactam drugs. As a routine the 
orthopaedician should ask for bacterial cultural sensitivity for Chronic 
Osteomyelitis. As anaerobes and gram negative bacilli constitute a major 
proportion of  Chronic Osteomyelitis , culture and sensitivity should be 
done for both the organisms. Patients’ hospital stay duration should be 
minimised and out-patient treatment with oral drugs should be encouraged. 
Prevention is better than cure. Strict asepsis should be maintained during 
any operative procedures.  
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The spread of MRSA from fomites and gram negative bacilli from 
cheatle forceps, hospital environment can be prevented. The use of towels, 
handkerchiefs between patients and their attenders should be discouraged. 
The therapeutic approach directed towards organisms forming biofilm will 
bring down incidence of Chronic Osteomyelitis to a large extent in the near 
future. 
 
Scope  for further  research 
Continued surveillance for incidence of drug resistance among the 
microorganisms causing chronic osteomyelitis should be done in our 
medical college.  
Updating the antimicrobial policies based on the sensitivity pattern 
should also be done. 
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ANNEXURES 
 
PROFORMA 
  
NAME:                                                       SERIAL NO: 
  
AGE:      LAB NO: 
 
SEX:                                                          OP/IP NO: 
 
ADDRESS:                                               DATE OF Sample collection: 
OCCUPATION: 
INCOME: 
Chief Complaints: 
 Pain: 
 Discharging sinus: 
 Any restricted joint movements:  
H/O Present illness:  
 Duration of the disease 
 Presence of Diabetic Ulcer 
 Lymphedema 
 Presence of cellulitis 
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Past History: 
 Road traffic accidents 
 Trauma 
 History of Hypertension 
 Smoking 
 Diabetes 
Personal history: 
General Examination: 
 Pulse rate 
 Heart rate 
 Temperature 
 Anaemia 
 Presence of malnutrition 
Systemic examination: 
 CVS 
  RS   
 CNS 
 P/A 
Clinical diagnosis: 
 X-ray 
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WORKSHEET 
Specimen:                                                   
Bone Aspirate (or) Bone Curretings: 
FOR  ISOLATION OF  BACTERIA: 
Culture: 
 MacConkey Agar 
 Nutrient agar 
 Blood Agar 
Biochemical reactions: 
 Catalase 
 Oxidase 
 Motility 
 IMViC  
 Urease 
 TSI 
 LAO 
 OF Test 
 Coagulase 
 Sugar fermentation tests 
Culture Report: 
Antimicrobial Susceptibility: 
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GRAM STAINING 
The gram stain was prepared as follows: 
PRIMARY DYE: 
Crystal violet                            - 10g 
Ammonium oxalate                 - 4.25g 
Absolute alcohol                       - 50ml 
Distilled water                        -500ml 
The methyl violet dye was dissolved in 50 ml absolute alcohol and mixed thoroughly. 
Then ammonium oxalate 4.25 g was dissolved in 100 ml of distilled water and this 
mixture was added to the violet stain and finally distilled water was added to make 500 
ml. The total mixture was filtered before use. 
Gram’s iodine solution consists of the following 
Iodine             - 25g 
KI                  - 50G 
DW               - 500ml 
 
Fifty grams of KI was dissolved in 500 ml of water and then 25 grams of iodine was 
added to that. When iodine is dissolved, the solution was made up to 500ml with distilled 
water. 
Counter stain used in grams stain was dilute carbol fuschin. It consists of the following: 
Basic fuschin         - 5g 
Phenol                   -25g 
Absolute alcohol   -50 ml 
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The basic fuschin powder was added to alcohol at intervals until it was dissolved. Then 
phenol too was dissolved in distilled water. Both the solution was mixed in a separate 
container. 
 
CATALASE TEST: 
Done by both slide & tube methods. 
Tube method: 
A small amount of the culture was picked up from the nutrient agar plate with a clean, 
sterile glass rod and inserted into a tube of 3% hydrogen peroxide; there was no 
effervescence or bubble formation. 
Slide method: 
Pure growth of the organism from the agar was transferred to a clean slide with a sterile 
glass rod. Immediately 2 to 3 drops of 3% hydrogen peroxide was added to the growth, 
observed for the release of the bubbles. 
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MEDIA PREPARATION 
1. Peptone water: 
            Peptone               1 g         
           Sodium chloride   0.5 g 
           Distilled water      100 ml              PH – 7.4 
  Sterilise by autoclaving at 121d C for 15 minutes. 
2. Nutrient broth : 
           Peptone water     100ml    
           Beef extract         1 g 
           Ph                       7.4 
  Sterilise by autoclaving at 121dC for 15 minutes. 
   
3. Nutrient agar : 
   To the nutrient broth, add required amount of agar. Steam to dissolve agar, 
filter, and adjust ph to 7.4. Sterilise by autoclaving at 121dC for 15 min. 
4. Blood agar : 
    To the 100 ml of nutrient agar, in water bath at 50dC, add 5% (5ml) of   Sheep 
blood. 
5. Mac conkey agar 
                Peptone                         20 g     
                Sodium chloride            5 g               
                Sodium taurocholate     5 g              
                Lactose                          10g              
                Neutral red                    10 ml                 
                Agar                              15 g                 
               Distilled water               1000 ml 
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         Sterilise by autoclaving at 121dC for 15 minutes. 
 
       
6.  Muller Hinton media: 
         Beef infusion                  300 g/l          
         Casein acid hydrolysate    17.5 g  
         Starch                               1.5 g           
         Agar                                 17 g           
        Distilled water                  1000 ml              
Sterilise by autoclaving at 121dC for 15 minutes. 
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